- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ImmuCell Corporation (ICCC)
The ImmuCell share price today is 10.060, view NASDAQ ICCC stock exchange data. Track the latest ImmuCell share price with real-time updates on ICCC stock performance including market cap, day range, 52-week range and dividend yield. Access ICCC charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.050
10.493
52 wk Range
4.520
12.100
ICCC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.05010.493
52 wk Range
4.52012.100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ICCC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Cash flows can sufficiently cover interest payments
ImmuCell CEO buys $75,960 in common stock- Investing.com
Form 4 ImmuCell Corporation For: 22 June- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Buy
Moving Averages
Strong Sell
ImmuCell Corporation Earnings Call Summary for Q2/2026
- ImmuCell Q2 2026 revenue rose 11.5% to $7.18M; net income tripled to $1.8M ($0.20/share), aided by $2M one-time legal settlement.
- Gross margin fell sharply to 33.9% from 43.7% year-over-year due to manufacturing costs and product mix shifts, pressuring investor sentiment.
- Domestic sales surged 27.7% to $6.2M driven by First Defense market share gains (15% to 19%), but international sales dropped 38.9% to $1M.
- Company plans $8M capacity expansion through 2027 to triple output and cut processing time from 2-3 months to under one month.
- Stock fell 5.64% to $10.285 despite strong results; InvestingPro flags shares as overvalued after 77% year-to-date gain.
Last Updated: 14-08-2026, 07:12 pm
Read Full TranscriptEarnings
Latest Release
13-08-2026
EPS / Forecast
0.20 / --
Revenue / Forecast
7.18M / --
Compare ICCC to Peers and Sector
Metrics to compare | ICCC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipICCCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 116.0x | −2.5x | −0.4x | |
PEG Ratio | −1.85 | −0.04 | 0.00 | |
Price/Book | 2.9x | 2.2x | 2.6x | |
Price / LTM Sales | 3.0x | 70.7x | 3.1x | |
Upside (Analyst Target) | - | 108.3% | 48.9% | |
Fair Value Upside | Unlock | 5.5% | 6.2% | Unlock |
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the ImmuCell (ICCC) Share Price Today?
The ImmuCell share price today is 10.060.
What is the current ImmuCell (ICCC) share price and day range?
As of 23-08-2026, the ImmuCell share price is 10.060, with a previous close of 10.090. The share price has ranged from 10.050 to 10.493 today, while the 52-week range spans from 4.520 to 12.100.
What Is the ImmuCell Market Cap?
As of today, ImmuCell market cap is 91.370M.
What Is ImmuCell's Earnings Per Share (TTM)?
The ImmuCell EPS (TTM) is 0.075.
When Is the Next ImmuCell Earnings Date?
ImmuCell will release its next earnings report on 12-11-2026.
From a Technical Analysis Perspective, Is ICCC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does ImmuCell Trade On?
ImmuCell is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for ImmuCell?
The stock symbol for ImmuCell is "ICCC."
How Many Times Has ImmuCell Stock Split?
ImmuCell has split 1 times.
How Many Employees Does ImmuCell Have?
ImmuCell has 73 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.